- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04081532
The Effectiveness of Laparoscopic Treatment of Superficial Endometriosis for Managing Chronic Pelvic Pain (ESPriT1)
December 3, 2019 updated by: University of Edinburgh
The Effectiveness of Laparoscopic Treatment of Isolated Superficial Peritoneal Endometriosis for Managing Chronic Pelvic Pain in Women: a Randomised Controlled Feasibility Trial
Endometriosis is a chronic, incurable condition that affects about 10% of women of reproductive age.
It is defined as a growth of cells similar to the womb lining outside of the womb in the pelvis, and is associated with chronic pelvic pain, excessive period pain, pain with sexual intercourse and difficulties in getting pregnant.
If the disease is found only on the lining of the pelvis it is known as "superficial peritoneal" and is usually treated during a laparoscopic surgery by cutting out (excision) or burning off (ablation).
However, many women do not find improvement in their symptoms after the surgery and can have complications from the procedure.
The aim of this study is to determine if removal of the superficial peritoneal endometriosis improves pain symptoms and quality of life, which method of removal (excision or ablation) is more effective or if surgical removal is of no benefit to the patients and can potentially cause harm.
The investigators plan to recruit up to 90 women from four NHS hospitals in Scotland over a period of 12 months.
Women who are attending gynaecology departments with pelvic pain who have not previously had a diagnosis of endometriosis via laparoscopy will be approached.
Patients will be asked to read an information sheet about the trial.
Women who consent to the trial will be randomised during the surgery, if superficial endometriosis is found, to either having the endometriosis removed or not.
For this pilot, follow up will be at 3 and 6 months (and obtain permission to continue to follow them up at 12 and 24 months should time and finding permit).
Patients who do not consent to take part in the trial will be asked if the investigators can collect data on their demographics and reasons on why they did not wish to take part.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Edinburgh, United Kingdom
- Recruiting
- Royal Infirmary of Edinburgh
-
Contact:
- Nicola Watson
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 55 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Undergoing laparoscopy for the investigation of chronic pelvic pain
- In order to be randomised, isolated superficial peritoneal endometriosis (SPE) must be identified at laparoscopy (macroscopically)
- Able to give informed consent
Exclusion Criteria:
- Previous surgical diagnosis of endometriosis
- Pregnant or are actively trying for pregnancy within the next six months
- Deep endometriosis or ovarian endometrioma on imaging or at laparoscopy
- Peritoneal 'pockets' only noted at laparoscopy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Surgical treatment
|
In the active comparator group patients will have endometriosis lesions removed by ablation or excision.
Patients randomised to no surgical treatment arm will not have lesions removed and will only be given diagnosis on whether endometriosis was found or not.
|
NO_INTERVENTION: No surgical treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of women with suspected SPE undergoing diagnostic laparoscopy that were approached for the study an agreed to randomisation
Time Frame: Screening
|
The proportion of screened women who are eligible for the trial determined from the screening logs
|
Screening
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Baseline characteristics of eligible women that agree to be randomised and those that decline participation
Time Frame: Screening
|
Baseline characteristics including age, social deprivation, ethnicity and duration of pain collected from screened women
|
Screening
|
Proportion of women having laparoscopy for investigation of chronic pelvic pain that are eligible (i.e. have only SPE) for the trial
Time Frame: visit 2 (day of surgery)
|
The proportion of women undergoing diagnostic laparoscopy who go on to be diagnosed with SPE
|
visit 2 (day of surgery)
|
Effects of treatment and variability in treatment outcomes
Time Frame: visit 2 (day of surgery), 30 days post surgery
|
Intraoperative and postoperative complications
|
visit 2 (day of surgery), 30 days post surgery
|
Improvement in quality of life
Time Frame: 30 days post surgery, follow up at 3 and 6 months
|
Endometriosis Health Profile-30 (EHP-30)
|
30 days post surgery, follow up at 3 and 6 months
|
Improvement in quality of life
Time Frame: day of surgery, follow up at 3 and 6 months
|
Rome IV criteria
|
day of surgery, follow up at 3 and 6 months
|
Improvement in quality of life
Time Frame: day of surgery, follow up at 3 and 6 months
|
Pelvic Pain and Urgency/Frequency Patient (PUF) Symptom Scale
|
day of surgery, follow up at 3 and 6 months
|
Improvement in quality of life
Time Frame: day of surgery, follow up at 3 and 6 months
|
PainDetect TM
|
day of surgery, follow up at 3 and 6 months
|
Improvement in quality of life
Time Frame: day of surgery, follow up at 3 and 6 months
|
Brief Fatigue Inventory (BFI)
|
day of surgery, follow up at 3 and 6 months
|
Improvement in quality of life
Time Frame: day of surgery, follow up at 3 and 6 months
|
Pain Catastrophising Questionnaire (PCQ)
|
day of surgery, follow up at 3 and 6 months
|
Improvement in quality of life
Time Frame: day of surgery, follow up at 3 and 6 months
|
Fibromyalgia Scale
|
day of surgery, follow up at 3 and 6 months
|
Improvement in quality of life
Time Frame: day of surgery, follow up at 3 and 6 months
|
Measure Yourself Medical Outcome Profile 2 (MYMOP 2)
|
day of surgery, follow up at 3 and 6 months
|
Improvement in quality of life
Time Frame: day of surgery, follow up at 3 and 6 months
|
Working Productivity and Activity Impairment Questionnaire (WPAIQ)
|
day of surgery, follow up at 3 and 6 months
|
Improvement in quality of life
Time Frame: day of surgery, follow up at 3 and 6 months
|
EuroQol 5 Dimensions 5 Level Questionnaire (EQ-5D-5L)
|
day of surgery, follow up at 3 and 6 months
|
Effects of treatment and variability in treatment outcomes
Time Frame: 30 days post surgery, follow up at 3 and 6 months
|
Number of patients who needed analgesia after laparoscopy recorded during follow up.
|
30 days post surgery, follow up at 3 and 6 months
|
Effects of treatment and variability in treatment outcomes
Time Frame: 30 days post surgery, follow up at 3 and 6 months
|
Number of patients who needed medical management with ovarian suppression after laparoscopy recorded during follow up.
|
30 days post surgery, follow up at 3 and 6 months
|
Effects of treatment and variability in treatment outcomes
Time Frame: Throughout the trial starting from day of surgery until end of followup at 6 months
|
Adverse events (as reported by the participants)
|
Throughout the trial starting from day of surgery until end of followup at 6 months
|
To determine the most acceptable methods of recruitment and assessment tools
Time Frame: Questionnaires collected at Baseline (within a week of surgery), 3 and 6 months follow up
|
The proportion of completed trial questionnaires
|
Questionnaires collected at Baseline (within a week of surgery), 3 and 6 months follow up
|
To determine the most acceptable methods of assessment tools
Time Frame: Throughout the trial until end of follow up at 6 months
|
Number of patients who remained blinded for 6 months after the surgery recorded by asking patient if they were told their allocation
|
Throughout the trial until end of follow up at 6 months
|
To determine the most acceptable methods of recruitment, randomisation and assessment tools
Time Frame: 6 months follow up
|
Acceptability of the trial completed at 6 months after surgery will be compared between two arms.
|
6 months follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 30, 2019
Primary Completion (ANTICIPATED)
May 1, 2020
Study Completion (ANTICIPATED)
August 1, 2020
Study Registration Dates
First Submitted
August 15, 2019
First Submitted That Met QC Criteria
September 4, 2019
First Posted (ACTUAL)
September 9, 2019
Study Record Updates
Last Update Posted (ACTUAL)
December 5, 2019
Last Update Submitted That Met QC Criteria
December 3, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- AC19062
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endometriosis
-
Fabio BarraCompletedEndometriosis | Endometriosis, Rectum | Endometriosis of Vagina | Endometriosis Rectovaginal Septum | Endometriosis Pelvic | Endometriosis of ColonItaly
-
Ospedale Policlinico San MartinoCompletedEndometriosis | Bowel Endometriosis | Endometriosis, Rectum | Endometriosis ColonItaly
-
BioGene Pharmaceutical Ltd.WithdrawnSafety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis (ELTA)Endometriosis | Endometriosis Ovary | Endometriosis, Rectum | Endometriosis ExternaSwitzerland
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...CompletedEndometriosis | Endometriosis-related Pain | Endometriosis Thoracic | Endometriosis of Lung | Endometriosis of PleuraItaly
-
Ospedale Policlinico San MartinoCompletedEndometriosis, Rectum | Endometriosis, SigmoidItaly
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaUnknownBowel Endometriosis | Endometriosis, RectumItaly
-
Ospedale Policlinico San MartinoActive, not recruitingEndometriosis, Rectum | Endometriosis of ColonItaly
-
Catholic University of the Sacred HeartCompletedPelvic Endometriosis | Endometriosis Outside PelvisItaly
-
Semmelweis UniversityUniversity of PecsNot yet recruitingEndometriosis | Endometriosis Ovary | Endometriosis Rectovaginal Septum
-
Catholic University of the Sacred HeartCompletedPelvic Endometriosis | Endometriosis Outside PelvisItaly
Clinical Trials on surgical removal of superficial peritoneal endometriosis
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...CompletedEndometriosis | Endometriosis-related Pain | Endometriosis Thoracic | Endometriosis of Lung | Endometriosis of PleuraItaly
-
Beijing Tiantan HospitalUnknownLanguage | AVM - Cerebral Arteriovenous MalformationChina
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Prisma Health-UpstateTerminatedObesity | Wound ComplicationsUnited States
-
University of Illinois at Urbana-ChampaignU.S. National Science Foundation; Ss. Cyril and Methodius University of Skopje...Recruiting
-
University Hospital OstravaCompletedPapilloma | Nasal Polyps | Nasal DiseasesCzech Republic
-
Azienda Ospedaliera Universitaria Integrata VeronaFondazione Policlinico Universitario Agostino Gemelli IRCCS; Fondazione IRCCS... and other collaboratorsUnknown
-
Vanderbilt UniversityCompletedPituitary | Robotics | Sinus Surgery | Skull Base | Endonasal SurgeryUnited States
-
University Hospital, LilleNational Cancer Institute, FranceRecruitingGastric AdenocarcinomaFrance
-
National Naval Medical CenterNational Cancer Institute (NCI); Uniformed Services University of the Health...CompletedColorectal NeoplasmsUnited States